Safety evaluation of steviol glycoside preparations published by EFSA
Sep 01, 2021
The EFSA Panel on Food Additives and Flavourings (FAF) provides a scientific opinion on the safety of steviol glycoside preparations, including rebaudioside AM, obtained by enzymatic bioconversion of highly purified stevioside and/or rebaudioside A stevia leaf extracts. The Panel recommends the European Commission to consider the proposal of establishing separate specifications for steviol glycoside preparations, including rebaudioside AM, obtained by enzymatic bioconversion of highly purified stevioside and/or rebaudioside A stevia leaf extracts in Commission Regulation (EU) No 231/2012.
For further information (in English), click on the Link
The Regulation of Dietary Supplements in the United States
USA
Aug 04, 2022
Amendments to food regulations
Vietnam
Aug 04, 2022
Policy regarding N-acetyl-L-cysteine
USA
Aug 03, 2022
Regulation on supplementary food
Turkey
Jul 25, 2022
Amendments to the Food and Drug Regulations on supplemented foods
Canada
Jul 20, 2022
Amendments to Regulation on natural health products
Canada
Jul 18, 2022
USA - Lack of supplement regulation: A potential for ethical and physiological repercussions
USA
Jul 11, 2022
FTC bans marketing of supplements with claims related to heart protection
USA
Jul 06, 2022
Foods for special medical uses
South Korea
Jun 29, 2022
Monacolins from red yeast rice
European Union
Jun 13, 2022
New Dietary Supplement Education Initiative for Consumers, Educators, and Healthcare Professionals
USA
Jun 06, 2022
Guidance aims to increase safety information about dietary supplement marketplace
USA
May 19, 2022
What Should Dietary Supplement Oversight Look Like in the US?
USA
May 16, 2022
Directions on health supplements, nutraceuticals and other health products
India
May 12, 2022
Updates to the dietary supplement ingredient advisory list
USA
May 11, 2022
